Tasmanian devil's genome sequenced

A revolutionary species-preservation approach based on whole-genome analyses of two Tasmanian devils -- one that had died of a contagious cancer known as Devil Facial Tumor Disease (DFTD) and one healthy animal -- has been ...

Nanoparticles may cause DNA damage across a cellular barrier

(PhysOrg.com) -- Scientists have shown in the laboratory that metal nanoparticles damaged the DNA in cells on the other side of a cellular barrier. The research, by the University of Bristol, is published online this week ...

Two-In-One Punch Knocks Out Drug Resistant Cancer Cells

(PhysOrg.com) -- Cancer cells, like bacteria, can develop resistance to drug therapy, leading to relapse of disease. One approach showing promise in overcoming multidrug resistance in tumors is to combine two different anticancer ...

Tumors Feel the Deadly Sting of Nanobees

When bees sting, they pump into their victims a peptide toxin called melittin that destroys cell membranes. Now, by encapsulating this extremely potent molecule within a nanoparticle, researchers at the Washington University ...

page 1 from 13

Malignancy

Malignancy (from the Latin roots mal- = "bad" and -genus = "born") is the tendency of a medical condition, especially tumors to become progressively worse and to potentially result in death. It is characterized by the properties of anaplasia, invasiveness, and metastasis. Malignant is a corresponding adjectival medical term used to describe a severe and progressively worsening disease. The term is most familiar as a description of cancer. A malignant tumor may be contrasted with a non-cancerous benign tumor in that a malignancy is not self-limited in its growth, is capable of invading into adjacent tissues, and may be capable of spreading to distant tissues (metastasizing), while a benign tumor has none of those properties. Malignant tumor is synonymous with cancer. Uses of "malignant" in oncology:

Non-oncologic disorders referred to as "malignant":

This text uses material from Wikipedia, licensed under CC BY-SA